• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素与喷他脒治疗锑剂无反应性黑热病的对比

Amphotericin versus pentamidine in antimony-unresponsive kala-azar.

作者信息

Mishra M, Biswas U K, Jha D N, Khan A B

机构信息

Department of Medicine, Darbhanga Medical College & Hospital, Bihar, India.

出版信息

Lancet. 1992 Nov 21;340(8830):1256-7. doi: 10.1016/0140-6736(92)92952-c.

DOI:10.1016/0140-6736(92)92952-c
PMID:1359322
Abstract

We compared the efficacy of amphotericin B and pentamidine isethionate in a prospective randomised trial in 120 uncomplicated and parasitologically confirmed cases of antimony-unresponsive kala-azar. Doses were twenty intramuscular injections of pentamidine 4 mg/kg on alternate days or fourteen definitive doses of amphotericin 0.5 mg/kg infused in 5% dextrose on alternate days. 48 (80%) patients given pentamidine showed initial cure and 46 (77%) showed definitive cure compared with 60 (100%) and 59 (98%) cases, respectively, on amphotericin (p < 0.001). Amphotericin also brought about quicker abatement of fever and more complete spleen regression.

摘要

在一项前瞻性随机试验中,我们比较了两性霉素B和喷他脒异硫氰酸盐对120例未经复杂治疗且经寄生虫学确诊的锑无反应型黑热病病例的疗效。剂量为每两天肌肉注射20次,每次喷他脒4mg/kg,或每两天在5%葡萄糖中静脉输注14次,每次两性霉素0.5mg/kg。接受喷他脒治疗的48例(80%)患者初步治愈,46例(77%)最终治愈,而接受两性霉素治疗的患者分别为60例(100%)和59例(98%)(p<0.001)。两性霉素还能更快地退热,脾脏回缩更完全。

相似文献

1
Amphotericin versus pentamidine in antimony-unresponsive kala-azar.两性霉素与喷他脒治疗锑剂无反应性黑热病的对比
Lancet. 1992 Nov 21;340(8830):1256-7. doi: 10.1016/0140-6736(92)92952-c.
2
Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.两性霉素与葡萄糖酸锑钠在印度黑热病一线治疗中的对比
Lancet. 1994 Dec 10;344(8937):1599-600. doi: 10.1016/s0140-6736(94)90406-5.
3
Experience with amphotericin B in sodium stibogluconate--unresponsive cases of visceral Leishmaniasis in north Bihar.两性霉素B治疗葡糖酸锑钠无反应的比哈尔邦北部内脏利什曼病病例的经验。
J Assoc Physicians India. 1994 Sep;42(9):690-1.
4
Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study.
Am J Trop Med Hyg. 1991 Oct;45(4):435-41. doi: 10.4269/ajtmh.1991.45.435.
5
[Treatment of visceral leishmaniasis or kala-azar (author's transl)].内脏利什曼病或黑热病的治疗(作者译)
Med Trop (Mars). 1978 Jul-Aug;38(4):401-4.
6
Observations on the effect of verapamil with sodium stibogluconate in kala azar.
Trop Geogr Med. 1992 Jan;44(1-2):15-8.
7
Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.接受注射用抗利什曼原虫药物治疗的印度黑热病患者中的乙型和丙型肝炎病毒感染:一项基于社区的研究。
Int J Infect Dis. 2000;4(4):203-8. doi: 10.1016/s1201-9712(00)90110-3.
8
Kala-azar in Bihar.比哈尔邦的黑热病
Indian J Pediatr. 1987 Jan-Feb;54(1):103-10. doi: 10.1007/BF02751248.
9
Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India.在印度比哈尔邦农村地区进行的两性霉素B治疗黑热病的观察。
Indian J Med Res. 2001 Jan;113:14-8.
10
Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).比哈尔邦黑热病(包括黑热病后皮肤利什曼病)的流行病学、临床及治疗特征
Trans R Soc Trop Med Hyg. 1984;78(3):391-8. doi: 10.1016/0035-9203(84)90131-7.

引用本文的文献

1
Investigation of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-chromen-2-one as a promising coumarin compound for the development of a new and orally effective antileishmanial agent.对8-甲氧基-3-(4-硝基苯甲酰基)-6-丙基-2H-色原酮-2-酮作为一种有前景的香豆素类化合物用于开发新型口服有效抗利什曼原虫药物的研究。
Mol Biol Rep. 2020 Nov;47(11):8465-8474. doi: 10.1007/s11033-020-05887-5. Epub 2020 Oct 6.
2
Chemotherapeutics of visceral leishmaniasis: present and future developments.内脏利什曼病的化疗药物:现状与未来发展
Parasitology. 2018 Apr;145(4):481-489. doi: 10.1017/S0031182017002116. Epub 2017 Dec 7.
3
Identification and Characterization of miRNAs in Response to Infection: Delineation of Their Roles in Macrophage Dysfunction.
响应感染的微小RNA的鉴定与表征:阐明它们在巨噬细胞功能障碍中的作用
Front Microbiol. 2017 Mar 2;8:314. doi: 10.3389/fmicb.2017.00314. eCollection 2017.
4
Attenuation and Production of the Amphotericin B-Resistant Leishmania tropica Strain.抗两性霉素B热带利什曼原虫菌株的减毒与产生
Jundishapur J Microbiol. 2016 May 14;9(6):e32159. doi: 10.5812/jjm.32159. eCollection 2016 Jun.
5
Recent developments and future prospects in the treatment of visceral leishmaniasis.内脏利什曼病治疗的最新进展与未来前景
Ther Adv Infect Dis. 2016 Jun;3(3-4):98-109. doi: 10.1177/2049936116646063. Epub 2016 Apr 22.
6
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.从公共卫生角度看印度内脏利什曼病治疗方案的当前挑战
Infect Dis Poverty. 2016 Mar 8;5:19. doi: 10.1186/s40249-016-0112-2.
7
Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.锌(II)-二吡啶甲胺配位络合物作为杜氏利什曼原虫的靶向和化疗药物
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2932-40. doi: 10.1128/AAC.00410-16. Print 2016 May.
8
Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach.鉴定促进利什曼病愈合反应的Th1/Th2调节开关:一种计算方法。
EURASIP J Bioinform Syst Biol. 2015 Dec 1;2015(1):13. doi: 10.1186/s13637-015-0032-7. eCollection 2015 Dec.
9
Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.婴儿利什曼原虫分离株对来自锑治疗难治性患者的一氧化氮具有交叉抗性,并且对巨噬细胞的抗利什曼原虫反应具有更高的耐受性。
Parasitol Res. 2016 Feb;115(2):713-21. doi: 10.1007/s00436-015-4793-4.
10
An update on pharmacotherapy for leishmaniasis.利什曼病药物治疗的最新进展。
Expert Opin Pharmacother. 2015 Feb;16(2):237-52. doi: 10.1517/14656566.2015.973850. Epub 2014 Oct 25.